Segulah sells CCS to trade

The sale ends an eight-year holding period for Segulah's fourth fund, which was the second Segulah fund to invest in the business following a one-year holding period for Segulah II between 2003-2004.

Segulah supported several bolt-on acquisitions and also made partial divestments during its most recent holding period. Segulah's most recent divestments was the sale of the cosmetics business in January 2019.

The healthcare business now employs 125 people and generates sales of SEK 440m.

Kiilto is a family-owned Finnish business founded in 1919, it employs 800 people and generates sales of €165m.

Previous funding
Segulah II acquired CCS in 2003 and later sold it to US-based CB Fleet in 2005.

Segulah IV acquired both CCS and Opus Health Care in 2011, and merged them under the CCS brand.

Company
Established in 1979, CCS is a producer and distributor of personal care products for dental care, pharmaceuticals for skin and eyes, and gastroenterology products. The company supplies pharmacies in Sweden, the rest of the Nordic region and the UK.

People
Segulah – Erik Thornell (partner).
Kiilto – Kari Laakso (CEO).
CCS Healthcare – Dario Aganovic (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Nordics
• Healthcare
• Segulah
• Trade sale
• Sweden